Middle Or Low Locally Advanced Resectable Rectal Carcinoma clinical trials

Explore recruiting middle or low locally advanced resectable rectal carcinoma clinical trials.

Also recruiting in Europe

Middle Or Low Locally Advanced Resectable Rectal Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

NORAD01 - Non inferiority multicenter phase III randomized trial comparing preoperative chemotherapy only to chemotherapy followed by chemoradiotherapy for locally advanced resectable rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE).

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Middle Or Low Locally Advanced Resectable Rectal Carcinoma trials by city

Middle Or Low Locally Advanced Resectable Rectal Carcinoma in Toronto Middle Or Low Locally Advanced Resectable Rectal Carcinoma in Vancouver Middle Or Low Locally Advanced Resectable Rectal Carcinoma in Montreal Middle Or Low Locally Advanced Resectable Rectal Carcinoma in Calgary Middle Or Low Locally Advanced Resectable Rectal Carcinoma in Edmonton Middle Or Low Locally Advanced Resectable Rectal Carcinoma in Ottawa Middle Or Low Locally Advanced Resectable Rectal Carcinoma in Winnipeg Middle Or Low Locally Advanced Resectable Rectal Carcinoma in Quebec City Middle Or Low Locally Advanced Resectable Rectal Carcinoma in Hamilton Middle Or Low Locally Advanced Resectable Rectal Carcinoma in Kitchener Middle Or Low Locally Advanced Resectable Rectal Carcinoma in London Middle Or Low Locally Advanced Resectable Rectal Carcinoma in Halifax Middle Or Low Locally Advanced Resectable Rectal Carcinoma in New York Middle Or Low Locally Advanced Resectable Rectal Carcinoma in Los Angeles Middle Or Low Locally Advanced Resectable Rectal Carcinoma in Chicago Middle Or Low Locally Advanced Resectable Rectal Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease